Finance

Lists
INDGN:NSE
Indegene Ltd
₹595.00
+0.72%
(+4.25) 1D
Oct 1, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for INDGN...
Open
₹587.00
High
₹601.55
Low
₹580.00
Mkt. cap
143.37B
Avg. vol.
692.30K
Volume
485.93K
Dividend
0.38%
Quarterly dividend
₹0.56
Ex-dividend date
Jul 31, 2026
P/E ratio
35.80
52-wk high
₹627.00
52-wk low
₹414.00
EPS
₹16.62
No. of employees
5K
Open
₹587.00
High
₹601.55
Low
₹580.00
Mkt. cap
143.37B
Avg. vol.
692.30K
Volume
485.93K
Dividend
0.38%
Quarterly dividend
₹0.56
Ex-dividend date
Jul 31, 2026
P/E ratio
35.80
52-wk high
₹627.00
52-wk low
₹414.00
EPS
₹16.62
No. of employees
5K
News stories
From web sources and news partners
Profile
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
About Indegene Ltd
CEOManish Gupta
Employees4.69K
Founded1998
Headquarters-
SectorHealth care
Websiteindegene.com
Last report
Jul 30, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹4.81 / ₹4.62
+4.00%beat
Revenue / Est. (INR)
10.63B / 10.56B
+0.63%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.04B
9.42B
10.03B
10.63B
Cost of goods sold
-
-
778.00M
-
Cost of revenue
-
-
778.00M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.16B
5.68B
6.39B
6.59B
Operating expense
6.87B
8.22B
7.99B
9.33B
Total operating expenses
6.87B
8.22B
8.77B
9.33B
Operating income
1.17B
1.20B
1.26B
1.30B
Other non operating income
197.00M
194.00M
-620.00M
290.00M
EBT including unusual items
1.33B
1.35B
1.05B
1.53B
EBT excluding unusual items
1.33B
1.35B
944.00M
1.53B
Income tax expense
310.00M
318.00M
254.00M
365.00M
Effective tax rate
23.29%
23.61%
24.17%
23.90%
Other operating expenses
1.48B
2.15B
1.18B
2.30B
Net income
1.02B
1.03B
797.00M
1.16B
Net profit margin
12.70%
10.92%
7.94%
10.93%
Earnings per share
4.23
4.26
3.94
4.81
Interest and investment income
-
-
363.00M
-
Interest expense
-38.00M
-46.00M
-39.00M
-64.00M
Net interest expenses
-38.00M
-46.00M
324.00M
-64.00M
Depreciation and amortization charges
234.00M
396.00M
418.00M
441.00M
EBITDA
1.40B
1.33B
1.49B
1.53B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps